The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Open accessAbstract
Peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ modulate lipid homeostasis. PPARα regulates lipid metabolism in the liver, the organ that largely controls whole-body nutrient/energy homeostasis, and its abnormalities may lead to hepatic steatosis, steatohepatitis, steatofibrosis, and liver cancer. PPARβ/δ promotes fatty acid β-oxidation largely in extrahepatic organs, and PPARγ stores triacylglycerol in adipocytes. Investigations using liver-specific PPAR-disrupted mice have revealed major but distinct contributions of the three PPARs in the liver. This review summarizes the findings of liver-specific PPAR-null mice and discusses the role of PPARs in the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Self-citationActivation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
β-Hydroxybutyrate: A Signaling Metabolite
Newman, J. C., & Verdin, E. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064916 · Cited by 872 · cited 1×
“Recently, ketone bodies have attracted attention as not only an energy source of the brain, but also a substance correcting metabolic disease and preventing aging and cancer [25].”
BackgroundAoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863
Self-citationIdentification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 736
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Self-citationPPARs at the crossroads of lipid signaling and inflammation
Wahli, W., & Michalik, L. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.001 · Cited by 675
Yu, S., Matsusue, K., Kashireddy, P., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210062200 · Cited by 619
Self-citationFrom NAFLD to NASH to cirrhosis—new insights into disease mechanisms
Wree, A., Broderick, L., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.149 · Cited by 609
Matsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
Self-citationPPARδ regulates glucose metabolism and insulin sensitivity
Lee, C.-H., Olson, P., Hevener, A., Mehl, I., Chong, L.-W., Olefsky, J. M., Gonzalez, F. J., Ham, J., Kang, H., Peters, J. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511253103 · Cited by 497
Self-citationPeroxisome proliferator-activated receptors and hepatic stellate cell activation
Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F., Motomura, K., Anania, F. A., Willson, T. M., & Tsukamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006577200 · Cited by 473
Staels, B., Rubenstrunk, A., Noel, B., Rigou, G., Delataille, P., Millatt, L. J., Baron, M., Lucas, A., Tailleux, A., Hum, D. W., et al. (2013) · Hepatology · doi:10.1002/hep.26461 · Cited by 414
Morán‐Salvador, E., López‐Parra, M., García‐Alonso, V., Titos, E., Martínez‐Clemente, M., González‐Périz, A., López‐Vicario, C., Barak, Y., Arroyo, V., & Clària, J. (2011) · The FASEB Journal · doi:10.1096/fj.10-173716 · Cited by 389
Vallée, A., & Lecarpentier, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00745 · Cited by 374
Francque, S., Verrijken, A., Caron, S., Prawitt, J., Paumelle, R., Derudas, B., Lefebvre, P., Taskinen, M.-R., Van Hul, W., Mertens, I., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.019 · Cited by 357
Hepatic Steatosis in Leptin-Deficient Mice Is Promoted by the PPARγ Target Gene Fsp27
Matsusue, K., Kusakabe, T., Noguchi, T., Takiguchi, S., Suzuki, T., Yamano, S., & Gonzalez, F. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.003 · Cited by 347
Self-citationReddy, J. K., & Krishnakantha, T. P. (1975) · Science · doi:10.1126/science.1198095 · Cited by 344
Fatty acids, eicosanoids and PPAR gamma
Marion-Letellier, R., Savoye, G., & Ghosh, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.004 · Cited by 332
PPARδ is a very low-density lipoprotein sensor in macrophages
Chawla, A., Lee, C.-H., Barak, Y., He, W., Rosenfeld, J., Liao, D., Han, J., Kang, H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337331100 · Cited by 305
Gupta, R. A., Wang, D., Katkuri, S., Wang, H., Dey, S. K., & DuBois, R. N. (2004) · Nature Medicine · doi:10.1038/nm993 · Cited by 275
Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ
Wang, F., Mullican, S. E., DiSpirito, J. R., Peed, L. C., & Lazar, M. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314863110 · Cited by 255
Adiponectin, driver or passenger on the road to insulin sensitivity?
Ye, R., & Scherer, P. E. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.04.001 · Cited by 251 · cited 1×
“C rculating ad ponectin ould increa glucose uptake an FA oxidation in h patocy es by activating AMPK, thereby improving systemic insulin sensitivity and reducing liver steatosis [83].”
BackgroundPPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver1–3
Abdelmegeed, M. A., Yoo, S.-H., Henderson, L. E., Gonzalez, F. J., Woodcroft, K. J., & Song, B.-J. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135210 · Cited by 251
Self-citationCorton, J. C., Cunningham, M. L., Hummer, B. T., Lau, C., Meek, B., Peters, J. M., Popp, J. A., Rhomberg, L., Seed, J., & Klaunig, J. E. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.835784 · Cited by 238
A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use
Liu, S., Brown, J. D., Stanya, K. J., Homan, E., Leidl, M., Inouye, K., Bhargava, P., Gangl, M. R., Dai, L., Hatano, B., et al. (2013) · Nature · doi:10.1038/nature12710 · Cited by 231
Targeting nuclear receptors for the treatment of fatty liver disease
Tanaka, N., Aoyama, T., Kimura, S., & Gonzalez, F. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.011 · Cited by 212
Self-citationLuquet, S., Gaudel, C., Holst, D., Lopez-Soriano, J., Jehl-Pietri, C., Fredenrich, A., & Grimaldi, P. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.11.011 · Cited by 210
Inventing new medicines: The FGF21 story
Kharitonenkov, A., & Adams, A. C. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.12.003 · Cited by 198
The Wnt/β-catenin signaling pathway targets PPARγ activity in colon cancer cells
Jansson, E. Å., Are, A., Greicius, G., Kuo, I.-C., Kelly, D., Arulampalam, V., & Pettersson, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405928102 · Cited by 178
Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet
Motomura, W., Inoue, M., Ohtake, T., Takahashi, N., Nagamine, M., Tanno, S., Kohgo, Y., & Okumura, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.121 · Cited by 178
Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2
Lee, Y. K., Park, J. E., Lee, M., & Hardwick, J. P. (2018) · Liver Research · doi:10.1016/j.livres.2018.12.001 · Cited by 173
Qin, X., Xie, X., Fan, Y., Tian, J., Guan, Y., Wang, X., Zhu, Y., & Wang, N. (2008) · Hepatology · doi:10.1002/hep.22334 · Cited by 163
Lee, Y. J., Ko, E. H., Kim, J. E., Kim, E., Lee, H., Choi, H., Yu, J. H., Kim, H. J., Seong, J.-K., Kim, K.-S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203218109 · Cited by 163
Barroso, E., Rodríguez-Calvo, R., Serrano-Marco, L., Astudillo, A. M., Balsinde, J., Palomer, X., & Vázquez-Carrera, M. (2011) · Endocrinology · doi:10.1210/en.2010-1468 · Cited by 161
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist
Iwaisako, K., Haimerl, M., Paik, Y.-H., Taura, K., Kodama, Y., Sirlin, C., Yu, E., Yu, R. T., Downes, M., Evans, R. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202464109 · Cited by 157
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Tanaka, N., Kimura, T., Fujimori, N., Nagaya, T., Komatsu, M., & Tanaka, E. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i2.163 · Cited by 146
Self-citation13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cells
Altmann, R., Hausmann, M., Spöttl, T., Gruber, M. A., Bull, A. W., Menzel, K., Vogl, D., Herfarth, H. H., Schölmerich, J., Falk, W., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.027 · Cited by 140
Hellemans, K., Michalik, L., Dittie, A., Knorr, A., Rombouts, K., de Jong, J., Heirman, C., Quartier, E., Schuit, F., Wahli, W., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50015 · Cited by 137
Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα
Lü, Y., Liu, X., Jiao, Y., Xiong, X., Wang, E., Wang, X., Zhang, Z., Zhang, H., Pan, L., Guan, Y., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74438 · Cited by 132
Tanaka, N., Horiuchi, A., Yokoyama, T., Kaneko, G., Horigome, N., Yamaura, T., Nagaya, T., Komatsu, M., Sano, K., Miyagawa, S., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0370-5 · Cited by 131
Self-citationPeroxisome Proliferator-Activated Receptor-α Enhances Lipid Metabolism in a Skin Equivalent Model
Rivier, M., Safonova, I., Michel, S., Castiel, I., & Ailhaud, G. P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00939.x · Cited by 127
Narala, V. R., Adapala, R. K., Suresh, M. V., Brock, T. G., Peters-Golden, M., & Reddy, R. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085118 · Cited by 126 · cited 2×
“For example, long-chain fatty acids (FAs) and eicosanoids are typical endogenous ligands for PPARα and PPARβ/δ [5,6], whereas PPARγ is activated by arachidonic acid metabolites, such as 5-oxo-15(S)-hydroxyeicosatetraenoic acid and 5-oxo-eicosatetraenoic acid [7,8].”
BackgroundHepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
Zarei, M., Barroso, E., Palomer, X., Dai, J., Rada, P., Quesada‐López, T., Escolá‐Gil, J. C., Cedó, L., Zali, M. R., Molaei, M., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.008 · Cited by 124
Tanaka, N., Takahashi, S., Zhang, Y., Krausz, K. W., Smith, P. B. W., Patterson, A. D., & Gonzalez, F. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.02.012 · Cited by 123
Self-citationMorán‐Salvador, E., Titos, E., Rius, B., González‐Périz, A., García‐Alonso, V., López‐Vicario, C., Miquel, R., Barak, Y., Arroyo, V., & Clària, J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.023 · Cited by 121
PPARγ in Placental Angiogenesis
Nadra, K., Quignodon, L., Sardella, C., Joye, E., Mucciolo, A., Chrast, R., & Desvergne, B. (2010) · Endocrinology · doi:10.1210/en.2010-0131 · Cited by 120
Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya, T., Tanaka, N., Suzuki, T., Sano, K., Horiuchi, A., Komatsu, M., Nakajima, T., Nishizawa, T., Joshita, S., Umemura, T., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.033 · Cited by 120
Self-citationCitrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease
Komatsu, M., Yazaki, M., Tanaka, N., Sano, K., Hashimoto, E., Takei, Y., Song, Y., Tanaka, E., Kiyosawa, K., Saheki, T., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.05.016 · Cited by 110
Self-citationPPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
Palomer, X., Barroso, E., Pizarro‐Delgado, J., Peña, L., Botteri, G., Zarei, M., Aguilar-Recarte, D., Montori-Grau, M., & Vázquez‐Carrera, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030913 · Cited by 110
Chinetti, G., Fruchart, J., & Staels, B. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00006 · Cited by 108
Krey, G. D., Keller, H., Mahfoudi, A., Medin, J. A., Ozato, K., Dreyer, C., & Wahli, W. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90058-5 · Cited by 104
Haczeyni, F., Wang, H., Barn, V., Mridha, A. R., Yeh, M. M., Haigh, W. G., Ioannou, G. N., Choi, Y., McWherter, C. A., Teoh, N., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1072 · Cited by 103
Takeuchi, S., Matsuda, T., Kobayashi, S., Takahashi, T., & Kojima, H. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.08.011 · Cited by 100
Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology
Manickam, R., & Wahli, W. (2016) · Biochimie · doi:10.1016/j.biochi.2016.11.010 · Cited by 98
Zhang, N., Chu, E. S., Zhang, J., Li, X., Liang, Q., Chen, J., Chen, M., Teoh, N., Farrell, G. C., Sung, J. J. �., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2212 · Cited by 96
Brocker, C. N., Yue, J., Kim, D., Qu, A., Bonzo, J. A., & Gonzalez, F. J. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00205.2016 · Cited by 93
Self-citationTanaka, N., Takahashi, S., Matsubara, T., Jiang, C., Sakamoto, W., Chanturiya, T., Teng, R., Gavrilova, O., & Gonzalez, F. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.605980 · Cited by 91
Self-citationBrocker, C. N., Patel, D. P., Velenosi, T. J., Kim, D., Yan, T., Yue, J., Li, G., Krausz, K. W., & Gonzalez, F. J. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088419 · Cited by 90
Self-citationZingarelli, B., Piraino, G., Hake, P. W., O’Connor, M. P., Denenberg, A. G., Fan, H., & Cook, J. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091010 · Cited by 86
PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells
Álvarez-Guardia, D., Palomer, X., Coll, T., Serrano, L., Rodríguez‐Calvo, R., Davidson, M. M., Merlos, M., Kochairi, I. E., Michalik, L., Wahli, W., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.002 · Cited by 86
Chen, L., Li, L., Chen, J., Li, L., Zheng, Z., Ren, J., & Qiu, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6466 · Cited by 83
Yamazaki, T., Shiraishi, S., Kishimoto, K., Miura, S., & Ezaki, O. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.009 · Cited by 81
Establishing the Role of PPARβ/δ in Carcinogenesis
Peters, J. M., Gonzalez, F. J., & Müller, R. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.09.004 · Cited by 81
Self-citationModulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat Diets
Domínguez-Avila, J. A., González-Aguilar, G. A., ́Álvarez-Parrilla, E., & la Rosa, L. A. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071002 · Cited by 81
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα
Komatsu, M., Kimura, T., Yazaki, M., Tanaka, N., Yang, Y., Nakajima, T., Horiuchi, A., Fang, Z., Joshita, S., Matsumoto, A., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.011 · Cited by 77
Self-citationBojic, L. A., Telford, D. E., Fullerton, M. D., Ford, R. J., Sutherland, B. G., Edwards, J. Y., Sawyez, C. G., Gros, R., Kemp, B. E., Steinberg, G. R., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046037 · Cited by 75
Su, Q., Baker, C., Christian, P., Naples, M., Tong, X., Zhang, K., Sántha, M., & Adeli, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00438.2013 · Cited by 74
5-Oxo-ETE analogs and the proliferation of cancer cells
O’Flaherty, J. T., Rogers, L. C., Paumi, C. M., Hantgan, R. R., Thomas, L. R., Clay, C. E., High, K. P., Chen, Y. Q., Willingham, M. C., Smitherman, P. K., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.009 · Cited by 73
Lee, H. J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i45.12787 · Cited by 70
Ajmone‐Cat, M. A., D’Urso, M. C., di Blasio, G., Brignone, M. S., Simone, R. D., & Minghetti, L. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.11.012 · Cited by 69
Konstantinopoulos, P. A., Vandoros, G. P., Sotiropoulou‐Bonikou, G., Kominea, A., & Papavassiliou, A. G. (2006) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0112-y · Cited by 63
Temelkova-Kurktschiev, T. S., Markolf Hanefeld, E., Chinetti, G., Zawadzki, C., Haulon, S., Kubaszek, A., Koehler, C., Leonhardt, W., Staels, B., & Laakso, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032120 · Cited by 57
Smati, S., Régnier, M., Fougeray, T., Polizzi, A., Fougerat, A., Lasserre, F., Lukowicz, C., Tramunt, B., Guillaume, M., Burnol, A.-F., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.05.005 · Cited by 47
Li, J., Mihalcioiu, M., Li, L., Zakikhani, M., Camirand, A., & Kremer, R. B. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.10.010 · Cited by 43
Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
Nagaya, T., Tanaka, N., Kimura, T., Kitabatake, H., Fujimori, N., Komatsu, M., Horiuchi, A., Yamaura, T., Umemura, T., Sano, K., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.02.001 · Cited by 41
Self-citationPPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis
Hu, X., Tanaka, N., Guo, R., Yu, L., Nakajima, T., Gonzalez, F. J., & Aoyama, T. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.09.015 · Cited by 40
Self-citationSilva-Veiga, F. M., Rachid, T. L., de Oliveira, L., Graus‐Nunes, F., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.03.013 · Cited by 38
Wei, Z., Zhao, D., Zhang, Y., Chen, Y., Zhang, S., Li, Q., Zeng, P., Li, X., Zhang, W., Duan, Y., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.084 · Cited by 37
Lee, S., & Jia, Y. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000145 · Cited by 32
Nagaya, T., Tanaka, N., Komatsu, M., Ichijo, T., Sano, K., Horiuchi, A., Joshita, S., Umemura, T., Matsumoto, A., Yoshizawa, K., et al. (2008) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-008-0017-0 · Cited by 32
Self-citationNakajima, T., Yang, Y., Lu, Y., Kamijo, Y., Yamada, Y., Nakamura, K., Koyama, M., Yamaguchi, S., Sugiyama, E., Tanaka, N., et al. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.242.229 · Cited by 29
Self-citationBae, M., Rhee, S. D., Jung, W. H., Ahn, J. H., Song, B., & Cheon, H. G. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0313-3 · Cited by 26
Nakajima, T., Kamijo, Y., Huang, Y., Kimura, T., Tanaka, N., Sugiyama, E., Nakamura, K., Kyogashima, M., Hara, A., & Aoyama, T. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9454-6 · Cited by 24
Self-citationHepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice
Kimura, T., Nakajima, T., Kamijo, Y., Tanaka, N., Wang, L., Hara, A., Sugiyama, E., Tanaka, E., Gonzalez, F. J., & Aoyama, T. (2012) · PPAR Research · doi:10.1155/2012/174932 · Cited by 23
Self-citationBigagli, E., Toti, S., Lodovici, M., Giovannelli, L., Cinci, L., D’Ambrosio, M., & Luceri, C. (2018) · Lifestyle Genomics · doi:10.1159/000495516 · Cited by 22
Balandaram, G., Kramer, L. R., Kang, B.-H., Murray, I. A., Perdew, G. H., Gonzalez, F. J., & Peters, J. M. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.010 · Cited by 20
Self-citationSynthesis, biological evaluation and molecular modeling studies of the PPARβ/δ antagonist CC618
Kaupang, Å., Paulsen, S. M., Steindal, C. C., Ravna, A. W., Sylte, I., Halvorsen, T. G., Thoresen, G. H., & Hansen, T. V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.006 · Cited by 10
Kaupang, Å., Kase, E. T., Vo, C. X. T., Amundsen, M., Vik, A., & Hansen, T. V. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.12.012 · Cited by 5
Cited by
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Gawrieh, S., Noureddin, M., Loo, N., Mohseni, R., Awasty, V., Cusi, K., Kowdley, K. V., Lai, M., Schiff, E., Parmar, D., et al. (2021) · Hepatology · doi:10.1002/hep.31843 · Cited by 379
Badmus, O. O., Hillhouse, S. A., Anderson, C. D., Hinds, T. D., & Stec, D. E. (2022) · Clinical Science · doi:10.1042/cs20220572 · Cited by 370
Roth, K., Yang, Z., Agarwal, M., Liu, W., Peng, Z., Long, Z., Birbeck, J., Westrick, J., Liu, W., & Petriello, M. C. (2021) · Environment International · doi:10.1016/j.envint.2021.106843 · Cited by 307
Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
Tahri-Joutey, M., Andreoletti, P., Surapureddi, S., Nasser, B., Cherkaoui-Malki, M., & Latruffe, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168969 · Cited by 253
Metadata
- Authors
- Wang, Y., Nakajima, T., Gonzalez, F. J., & Tanaka, N.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-03-17
- Volume
- 21
- Issue
- 6
- Pages
- 2061
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3010649284
- Cited by
- 540
- References
- 99
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.